MOUNTAIN VIEW, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that its corporate presentation will be webcast live during the 10th Annual BIO CEO & Investor Conference on Monday, February 11, 2008 at 1:15 p.m. Eastern Time.
The presentation will be webcast from the Waldorf-Astoria Hotel in New York. To access the live presentation via the Web, please go to the Investor Relations tab at http://www.alexza.com or at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ALXA&item_id=17522 05. A replay of the Webcast will be made available approximately 24 hours after the live presentation and the replay will be archived for 14 days.
Alexza is a biopharmaceutical company focused on the development and
commercialization of novel, proprietary products for the treatment of acute
and intermittent conditions. The Company's technology, the Staccato(R)
system, vaporizes unformulated drug to form a condensation aerosol that
allows rapid systemic drug delivery through deep lung inhalation. The drug
is quickly absorbed through the lungs into the bloodstream, providing speed
of therapeutic onset that is comparable to intravenous administration, but
with greater ease, patient comfort and convenience. Alexza has six product
candidates in development; AZ-004 (Staccato loxapine) for the treatment of
acute agitation in schizophrenic and bipolar disorder patients, AZ-001
(Staccato prochlorperazine) for the acute treatment of migraine headaches,
AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches,
AZ-002 (Staccato alpr
|SOURCE Alexza Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved